Red Flags Women’s Health Products Must Never Miss
A quick note before today’s piece:
We’re hosting a virtual event on March 11 in commemoration of International Women’s Day 2026: “Breaking Barriers: Women. Health. Africa.”
We’re bringing together founders, clinicians, investors, and ecosystem leaders to explore what African women actually need from FemTech, what’s being built, and how we can move forward with innovation that’s grounded in reality.
If women’s health matters globally, then African women must be part of the conversation from the beginning.
Time: 10am EST (4pm WAT, 6pm EAT)
Learn more and register here or send an email to hello@ayomide.me for further details.
Now, to today’s critical topic: the red flags women’s health products must never ignore and how to build safety into your product without overstepping into medicine.
Every day, millions of women log symptoms into health apps: period dates, pain levels, bleeding patterns, and mood changes. These apps promise to help women understand their bodies and optimize their health. But many of these products are collecting data on symptoms that could signal serious medical conditions and saying nothing.
When a pregnant woman reports severe abdominal pain and bleeding, that’s not just data. It could be an ectopic pregnancy, a life-threatening emergency. And when your app stays silent, you’re not just failing your user; you’re potentially putting her life at risk.
Studies show that many gynecologic emergencies first present as the same symptoms that are commonly tracked in consumer apps. When digital products fail to escalate these appropriately, the risk isn’t just user harm; it’s liability, credibility loss, and regulatory exposure.
The question isn’t whether women’s health apps should detect red flags. It’s how to do it responsibly, effectively, and without creating unnecessary panic.
Every women’s health product exists in a gray zone between wellness tracking and clinical decision support. The responsibility isn’t to diagnose but to recognize when something is no longer routine.
Not every concerning symptom is an emergency, and not every app feature needs medical oversight. But if your product collects health data, you need to understand three critical distinctions:
The goal is simple:
Your app shouldn’t practice medicine, but it should never ignore danger signals.
Different products encounter different risks. Here’s an overview for each domain:
Emergency signals:
These patterns could signal hemorrhage, ectopic pregnancy, or malignancy. Your product should trigger clear emergency guidance: “This requires immediate medical attention. Please go to the nearest emergency room.”
Urgent signals:
Non-urgent but important:
These deserve educational prompts and referral suggestions, not silence.
Immediate escalation is needed when pregnancy plus pain or bleeding suggests ectopic risk.
Specialist referral triggers include:
Your role isn’t to promise success but to guide realistic timelines and appropriate next steps.
Red flags here may indicate endocrine emergencies:
These are not routine hormone fluctuations. Referral prompts should also appear for severe symptom progression, long-term amenorrhea, or signs of metabolic complications.
Postmenopausal bleeding is always abnormal and requires immediate evaluation. This cannot be emphasized enough.
Neurological symptoms, chest discomfort during hot flashes, or severe headaches require immediate escalation. Early perimenopause (before age 40), severe mood disruption, or bone concerns should prompt specialist evaluation guidance.
Obstetric emergencies demand crisis-level escalation:
Detection is both technical and human. Building effective red flag detection isn’t just about triggering alerts; it’s about doing it in a way that’s clinically accurate, user-friendly, and legally defensible.
Technical layer:
User experience: Alerts must be clear (not alarmist), actionable, contextual, and accessible for all literacy levels.
Example Alert Architecture:
Low concern: “You’ve logged irregular cycles for 3 months. While this can be normal, if it continues, consider discussing it with your healthcare provider.”
Moderate concern: “The bleeding pattern you’re experiencing should be evaluated by a healthcare provider. We recommend scheduling an appointment within the next week.”
High concern: “This symptom pattern requires medical evaluation within 24-48 hours. Please contact your healthcare provider.”
Emergency: “This requires immediate medical attention. Please go to the nearest emergency room.”
Users should always understand why an alert appears.
Guidelines from ACOG, ASRM, and menopause societies clearly define when symptoms demand evaluation. Your job as a builder is to translate those thresholds into product logic, not reinvent them.
The moment your product tracks health patterns, it enters a safety conversation. Risk increases when apps ignore obvious danger patterns, make unsupported reassurance claims, or blur wellness tracking with medical promises.
Smart builders treat safety as infrastructure, not an afterthought. Mitigation includes clinician-reviewed alert logic, transparent product boundaries, regular guideline updates, and incident response systems.
Run a quick audit before you ship, or if you’re already live:
☐ Have you mapped category-specific red flags?
☐ Do alerts escalate appropriately?
☐ Has a clinician reviewed your logic?
☐ Is emergency guidance clear?
☐ Have users tested alert comprehension?
Women trust your product with their health data. That trust comes with responsibility.
You don’t need to be a medical device to care about medical red flags. You don’t need FDA clearance to build responsible detection into your product. But you do need to understand what you’re tracking, what it could mean, and when silence becomes negligence.
The opportunity here is enormous: products that integrate intelligent escalation build trust, credibility, and long-term defensibility. And in women’s health, where symptoms are often normalized or dismissed, thoughtful red flag systems can literally change outcomes.
The goal here is urgency without exaggeration and reassurance without dismissal.
Dr. Ayomide Owodunni is a FemTech Credibility Advisor helping FemTech founders build products that can withstand regulatory scrutiny and investor due diligence.
Dublin-based Joii has turned menstrual flow into measurable clinical data, using evaluation pads and a smartphone camera to quantify blood loss in milliliters.
A certified UK Class I medical device, Joii shifts period conversations from anecdotal to evidence-based.
Because “I bleed heavily” hits differently when backed by numbers.
Your testimonial helps fellow FemTech professionals discover the clinical insights and credibility frameworks they’re searching for
